OpenVSafe by OpenVAERS
Search V-safe

VUK-14403-85933

2 vaccinations 0 coded responses 6 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
934 / CA
Registered
2022-02-17
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-09
    Dose 1 — Janssen/Johnson & Johnson
  2. 2022-02-17
    Registered in v-safe
  3. 2022-02-17
    Dose 2 — Pfizer-BioNTech
  4. 2022-02-17
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  5. 2022-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2022-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  7. 2022-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Nausea
    Adult check-in
  8. 2022-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  9. 2022-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Janssen/Johnson & Johnson No
22022-02-17Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.

Loading…